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What’s new? 
 Little is known about the prospective association between the hypertriglyceridaemic–
waist phenotype and risk of Type 2 diabetes among individuals with impaired fasting 
glucose, who are often seen in primary care clinics. 
 Individuals with the hypertriglyceridaemic–waist phenotype had an increased risk of 
developing Type 2 diabetes. 
 
Abstract 
Aim We aimed to determine the prospective association between baseline triglyceridaemic–
waist phenotypes and diabetic mellitus incidence in individuals with impaired fasting glucose 
seen in primary care. 
Methods A cohort of 1101 participants (84.4% of the recruited individuals) with impaired 
fasting glucose were recruited from three primary care clinics during regular follow-ups to 
monitor their chronic conditions. Baseline triglyceridaemic–waist phenotypes were divided 
into four groups: (1) normal waistline and triglyceride level (n = 252); (2) isolated central 
obesity (n = 518); (3) isolated high triglyceride level (n = 80); and (4) central obesity with 
high triglyceride level (i.e. hypertriglyceridaemic–waist phenotype) (n = 251). The presence 
of diabetes at follow-up was determined by fasting plasma glucose (≥ 7.0 mmol/l) and/or 2-h 
75-g oral glucose tolerance test (≥ 11.1 mmol/l) and/or HbA1c (47.5 mmol/mol; ≥ 6.5%) 
according to American Diabetes Association diagnostic criteria. Multivariable Cox 
proportional hazards regressions were established to assess the impact of different 
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Results After a mean follow-up period of 6.5 months (SD 4.7 months), the number of 
diabetes cases was significantly higher in the group with hypertriglyceridaemic–waist 
phenotype (52.2%) compared with the other three phenotype groups (group 1: 28.2%; group 
2: 34.6%; group 3: 30.0%). Only the hypertriglyceridaemic–waist phenotype showed an 
increased risk of developing diabetes (hazard ratio 1.581, 95% CI 1.172–2.134; P = 0.003) 
compared with the group with normal waistline and triglyceride level after controlling for 
confounders. 
Conclusion The combination of central obesity and hypertriglyceridaemia is associated with 
> 50% risk of progression to diabetes within 6 months among individuals with impaired 
fasting glucose seen in primary care. 
Introduction 
With the development of modern society, lifestyle changes towards longer sedentary periods 
and over-nutrition, together with genetic susceptibility have led to increased body weight and 
waist circumference, and subsequently contributed to an epidemic of diabetes mellitus. It has 
been estimated that the prevalence of diabetes was 415 million in 2015, and this is expected 
to increase to 642 million by 2040 [1]. A major global non-communicable disease, diabetes 
accounted for an estimated 5 million deaths worldwide in 2015 [1]. 
Fasting plasma glucose (FPG) screening is the most popular method of testing for diabetes in 
primary care clinics in Hong Kong due to its convenience and low cost [2]. Therefore, 
impaired fasting glucose (IFG), a precursor of diabetes defined as a FPG level higher than 
normal but lower than that signifying diabetes [3], could be readily identified. It is important 
to treat people with IFG early to prevent or delay the development of diabetes, because 
people with IFG usually have a high risk of developing diabetes, with an annualized 
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of IFG is high. In a 2010 cross-sectional survey of a nationally representative sample of 
Chinese speakers, the prevalence of IFG among adults aged > 18 years was ~ 22.8% [6]. As a 
result, population interventions in all those with IFG are unlikely to be practical because of 
the cost and work involved, although current evidence suggests that diabetes can be 
prevented by changing behaviours or medication [7–10]. By contrast, targeted preventive 
interventions among those with a high probability of progressing to diabetes might be cost-
effective. 
The concept of a ‘hypertriglyceridaemic–waist phenotype’, i.e. central obesity and a high 
triglyceride level, was first used as a proxy to identify people at risk of developing 
cardiovascular disease [11]. Both central obesity and hypertriglyceridaemia are indicators of 
excess visceral adiposity, a well-establish risk factor for insulin resistance and disturbed 
glucose metabolism [12] that is independently associated with incident prediabetes and 
diabetes [13]. A systematic review of longitudinal studies showed that the incidence of 
diabetes increased 2.14 times (95% CI 1.70–2.71) in people with central obesity compared 
with those with a normal waist circumference [14]. In addition, previous studies have also 
demonstrated an association between elevated triglyceride levels and an increased risk of 
diabetes incidence [15,16]. Based on this evidence, the hypertriglyceridaemic–waist 
phenotype was found to be closely related to diabetes risk in the general population [17] and 
in those with impaired glucose tolerance [18]. However, whether it is associated with 
diabetes risk in people with IFG, a group that could be identified easily in primary care 
clinics, has been little studied. Here, we aimed to assess distribution of the triglyceridaemic–
waist phenotypes among people diagnosed with IFG in primary care settings and the impact 
of different triglyceridaemic–waist phenotypes on the time to diabetes onset using 
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Methods 
Study design and participant recruitment 
Participants in this cohort study were recruited from among individuals with chronic illness 
(except diabetes) that were managed at public primary care clinics in Hong Kong. Details of 
the study design and participant recruitment have been reported previously [9,19]. In brief, 
people attending public primary care clinics in Hong Kong undergo FPG testing if they are at 
risk of developing Type 2 diabetes, e.g. have hypertension, obesity or a positive family 
history of diabetes. Between May 2013 and February 2015, people attending three public 
primary care clinics in Hong Kong for routine chronic disease management were screened for 
eligibility. Individuals were included if they: were aged 18 years or above, without known 
history of diabetes, and had IFG defined by a plasma fasting glucose level between 5.6 and 
6.9 mmol/l according to the American Diabetes Association (ADA) criteria [3]. 
Exclusion criteria were: (1) individuals with known diabetes or who were taking anti-diabetic 
medication; (2) being pregnant or breastfeeding; (3) on glucocorticoid therapy; (4) having 
active thyroid disease; (5) having anaemia or taking an iron supplement; (6) having a history 
of blood donation or blood transfusion within 3 months preceding the recruitment; (7) with an 
estimated GFR < 30 ml/min/1.73m
2
 and (8) having missing clinical or laboratory information. 
In total, 1304 individuals meeting the selection criteria were recruited with written consent at 
baseline. The follow-up assessment was conducted during routine visits to the participating 
clinics for management of participants’ chronic conditions (except diabetes). We excluded 
203 individuals from the analysis (3 had known diabetes, 41 had anaemia or were taking an 
iron supplement, 35 had active thyroid disease, 66 had missing clinical or laboratory data at 
either baseline or follow-up, and 58 people had a too short a follow-up period, i.e. < 30 days). 
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date of last follow-up as censoring, or 15 February 2015, whichever came first. The current 
analysis included 1101 people (84.4%). 
This study protocol was registered at the Hong Kong Clinical Trial Centre (Ref: HKCTR-
1684) and ClinicalTrials.gov, the U.S. National Institutes of Health (Ref: NCT02439684). 
The study had received ethical approval by the institutional review board of the University of 
Hong Kong—the Hospital Authority Hong Kong West Cluster (Reference number: UW 13-
299) and the institutional review board of Joint Chinese University of Hong Kong—New 
Territories East Cluster CRE (Reference number: 2013.585). 
Outcome definition 
Participants were asked to fast overnight for at least 8 h prior to the day of the laboratory 
assessment. On the day of the assessment, two blood samples were taken: one fasting blood 
sample to assess levels of FPG and HbA1c, and a 2-h blood sampling after the 75-g oral 
glucose tolerance test (2h-OGTT). Blood samples were analysed at the Queen Mary Hospital 
or Prince of Wales Hospital laboratories, which have been accredited by the College of 
American Pathologists and are the providers of the usual laboratory service for the 
participating primary care clinics. Plasma glucose concentrations were measured using the 
Hexokinase method (Roche Cobas 8000), and HbA1c levels were measured using high-
performance liquid chromatography (Bio-Rad Variant II Turbo). 
Incident diabetes was the outcome of this study. Diabetes at follow-up was defined as FPG 
≥ 7.0 mmol/l and/or 2h-OGTT ≥ 11.1 mmol/l and/or HbA1c ≥ 47.5 mmol/mol (≥ 6.5%) 
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Exposure definition 
The triglyceridaemic–waist phenotypes were the exposures of this study. Waist 
circumference was measured while standing. Measurements were taken at a point midway 
between the iliac crest and the lower rib margin. Triglyceride level was determined from the 
fasting blood sample using enzymatic techniques. 
Four groups were defined according to the waist circumference and level of triglyceride: (1) 
normal waist circumference and triglyceride level, i.e. waist circumference < 80 cm in 
women and < 90 cm in men, and triglyceride level < 1.7 mmol/l; (2) isolated central obesity, 
i.e. waist circumference ≥ 80 cm in women and ≥ 90 cm in men, and normal triglyceride level; 
(3) isolated high triglyceride level, i.e. triglyceride level ≥ 1.7 mmol/l with normal waist 
circumference; and (4) central obesity with high triglyceride level. In particular, the group 
with central obesity and high triglyceride level was also referred to as the 
hypertriglyceridaemic–waist phenotype. 
Measurement of covariates 
The sociodemographic and lifestyle information was collected using a standardized 
questionnaire. Smoking status was categorized as never, ex and current smoker. Physical 
activity level was measured using the short form International Physical Activity 
Questionnaire (IPAQ) in accordance with the user manual. Daily time spent on moderate-to-
vigorous physical activity (MVPA) and sitting were collected [20]. BMI was calculated as 





) and obesity (≥ 25.0 kg/m
2
) in these Asian participants. Systolic 
and diastolic BP were measured at the participating clinic using an automated blood pressure 
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fasting blood sample using enzymatic techniques.  Levels of LDL cholesterol were calculated 
using the Friedewald equation for each individual [21]. 
Statistical analysis 
The baseline characteristics in groups with normal waistline and triglyceride level, isolated 
central obesity, isolated high triglyceride level, and central obesity with high triglyceride 
level were compared using one-way analysis of variance (ANOVA) for continuous data and 
χ
2
 test for categorical variables. Differences in diabetes incidence at follow-up among the 
four triglyceridaemic–waist phenotypes groups were compared using the χ
2
 test. All data 
were expressed as means and standard deviation (SD) for continuous data and number (%) for 
categorical data. 
Multivariable Cox proportional hazards regressions were established to measure the effect of 
triglyceridaemic–waist phenotypes on time to diabetes onset. A log-rank test was used to 
assess the significant difference in survival distributions between different triglyceridaemic–
waist phenotypes. Age, sex and baseline FPG were adjusted in Model 1. In Model 2, family 
history of diabetes, smoking status and systolic BP were further adjusted; and daily time 
spent on MVPA and sitting were additionally included in Model 3. 
All data analyses were performed with Stata/SE 13.0 (Stata-Corp, College Station, TX, USA). 
Statistical significance was set at P < 0.05. 
Results 
Of 1101 eligible participants, 252 (22.9%) had a normal waistline and triglyceride level, 518 
(47.0%) had isolated central obesity, 80 (7.3%) had isolated high triglyceride level and 251 
(22.8%) had central obesity and high triglyceride level. Table 1 shows a comparison of 
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triglyceride phenotype group. In general, compared with other triglyceridaemic–waist 
phenotypes, people with IFG and a hypertriglyceridaemic–waist phenotype, i.e. central 
obesity with high triglyceride level, were more likely to be male. They also spent less time on 
MVPA. 
After a mean follow-up of 6.5 months (SD 4.7 months), 405 (36.8%) individuals with IFG had 
progressed to diabetes according to FPG, HbA1c or 2h-OGTT criteria (Table 2). Compared 
with other triglyceridaemic–waist phenotypes, participants with central obesity and high 
triglyceride levels had the highest diabetes incidence under FPG, HbA1c and 2h-OGTT 
definitions, respectively. 
Table 3 shows the association between diabetes incidence and the triglyceridaemic–waist 
phenotypes. There was a significant difference in survival distributions between different 
triglyceridaemic–waist phenotypes assessed by log-rank test (P < 0.001). The results in Table 
3 show that the hypertriglyceridaemic–waist phenotype group had a significantly greater 
diabetes incidence than the reference category in Model 1 [hazard ratio (HR) 1.630, 95% CI 
1.210 – 2.196; P = 0.001]. After adjustment for other covariates and confounders, the trends 
were still significant (Model 2: HR 1.616, 95% CI 1.198–2.179; P = 0.002; Model 3: HR 
1.581, 95% CI 1.172–2.134; P = 0.003). There were no significant associations between 
isolated central obesity or isolated high triglyceride level and diabetes incidence at follow-up 
in any of the models. A plot of the survival curves is shown in Fig. 1. Individuals with the 
hypertriglyceridaemic–waist phenotype had significantly earlier onset of diabetes than the 
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Discussion 
In this cohort study of Chinese people with IFG, the hypertriglyceridaemic–waist phenotype, 
i.e. central obesity with a high triglyceride level, was associated with a higher risk of diabetes 
incidence, independent of measured confounders and physical activity level. This association 
was significant when diabetes was defined by FPG, 2h-OGTT or HbA1c. Our findings suggest 
that triglyceridaemic–waist phenotypes might be used as a simple tool to predict the risk of 
diabetes among people with IFG attending primary care clinics. 
The association between hypertriglyceridaemic–waist phenotype and risk of diabetes is in 
accordance with several previous studies [17,18,22]. A cohort study among Chinese urban 
adults showed that hypertriglyceridaemic–waist phenotype increased the risk of diabetes in 
both men (HR 4.46, 95% CI 1.88–10.60) and women (HR 4.64, 95% CI 1.20–17.97) [17]. In 
another longitudinal study of elderly men aged > 70 years, the hypertriglyceridaemic–waist 
phenotype was also associated with a more than fourfold increased risk of incident diabetes 
[relative risk (RR) 4.64, 95% CI 1.61–13.4] [22]. Additionally, a similar study conducted in 
Asian–Indian men with impaired glucose tolerance revealed that the hypertriglyceridaemic–
waist phenotype was independently associated with incident diabetes (HR 1.49, 95% CI 
1.01–2.21) [18]. Our study and the one conducted on impaired glucose tolerance [18] had a 
smaller effect size than studies conducted in a relatively healthier population [17,22]. This 
may be because the populations with IFG or impaired glucose tolerance already had impaired 
glucose metabolism. Therefore, they might develop diabetes because of the impaired glucose 
metabolism, regardless of their hypertriglyceridaemic–waist phenotype. 
There are several possible mechanisms underlying the association between 
hypertriglyceridaemic–waist phenotype and risk of diabetes. First, in our study, people with 
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higher BMI, both of which are well-established modifiable risk factors for diabetes [9,23]. 
Second, the hypertriglyceridaemic–waist phenotype was found to be associated with 
increased insulin resistance and decreased insulin sensitivity [22], which could increase the 
risk of developing diabetes due to the dysfunction of β cell. In addition, inflammation 
markers, such as high-sensitive C-reactive protein (hs-CRP) and interleukin 6, could increase 
the risk of diabetes [24]. Although a previous study [25] has shown that both central obesity 
and elevated triglyceride levels are associated with increased levels of inflammation markers 
and decreased levels of adiponectin, an insulin-sensitizing and anti-inflammatory adipokine 
in adipose tissues, the association between hypertriglyceridaemic–waist phenotype and risk 
of diabetes is plausible. 
In modern societies, unhealthy lifestyles, such as sedentary behaviours, limited physical 
activity and unhealthy eating habits dramatically increase the prevalence of central obesity 
and hypertriglyceridaemia [26,27]. Although several studies have demonstrated that the 
hypertriglyceridaemic–waist phenotype could identify individuals at high risk of developing 
diabetes in the general population [17], it is not feasible and cost-effective to screen waist 
circumference and triglyceride level for everyone. In addition, even though people with IFG 
represent a group with a high risk of developing diabetes and are usually encountered in 
primary care clinics, there are limited resources to intervene with every individual with IFG 
to prevent or delay the development of diabetes due to its high prevalence [6]. By contrast, 
our study highlighted the possibility of screening for the hypertriglyceridaemic–waist 
phenotype to identify individuals with IFG that were of increased risk of developing diabetes. 
This might serve as a potentially time- and cost-saving strategy to allocate resources to them 
to decrease the incident diabetes. 
Our study exhibits several strengths, including the cohort design and relative large sample 
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standardized measures across different participating clinics, which minimized measurement 
errors. In addition, our results were validated under different methods of diagnosing diabetes, 
suggesting the robustness of the findings. Some potential limitations of our study merit 
discussion. First, our study included individuals with IFG from public primary care clinics. 
The generalizability to other populations or medical settings, such as those from private 
clinics or hospitals, deserved further discussion. Second, the follow-up period was short. 
However, the follow-up test for each participant was conducted during regular appointments 
to monitor their chronic conditions in primary care clinics. It reflected the true situation in 
primary care. Third, participants were recruited solely based on their FPG level, regardless of 
their HbA1c and 2h-OGTT results at baseline, possibly leading to an overestimation of the 
incidence of diabetes at follow-up. Again, this was the true primary care situation in Hong 
Kong, where the FPG test is the most widely used method to screen for diabetes due to its 
low cost and convenience [2]. Fourth, a previous study has suggested that the association 
between hypertriglyceridaemic–waist phenotype and diabetes might be mediated through 
insulin resistance [18], something we were unable to confirm this study. In addition, follow-
up assessments were conducted during participants’ routine visits to the participating clinics 
to manage their chronic conditions. The time to diabetes onset is actually interval censored. 
Finally, several novel risk factors for diabetes, such as uric acid [28] and fetuin-A [29], have 
been recognized recently. Our study did not include measurements of these risk factors. 
In conclusion, in a cohort study among people with IFG, we found that those with the 
hypertriglyceridaemic–waist phenotype were more likely to progress to diabetes than 
individuals with normal waist circumference and triglyceride, or people with isolated central 
obesity or isolated high triglyceride levels, indicating that simultaneous measurement of waist 
circumference and triglyceride could serve as a simple screening tool to identify individuals 
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underscored the importance of measuring waist circumference and triglyceride level in 
primary care clinics. However, the cost-effectiveness and generalizability of such a tool 
should be evaluated in future studies. 
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FIGURE 1 Survival curve for the people with impaired fasting glucose who remained free of diabetes, stratified 
by triglyceridaemic–waist phenotypes. 
 
Table 1. Comparison of baseline demographic and clinical characteristics by the triglyceridaemic-waist 
phenotypes 


















n 252 518 80 251 − 
Demographic and lifestyle factors 
Mean age (years) 65.5 (9.1) 63.7 (8.8) 64.7 (8.9) 63.6 (8.8) 0.035* 
Male sex, n (%) 163 (64.7) 234 (45.2) 42 (52.5) 98 (39.0) < 0.001* 
Family history of diabetes, n 
(%) 
80 (31.7) 173 (33.4) 29 (36.3) 82 (32.7) 0.894 
Smoking status, n (%) 
     
 
Never smoker 186 (73.8) 422 (81.5) 64 (80.0) 207 (82.5) 0.146 
 
Ex-smoker 43 (17.1) 71 (13.7) 12 (15.0) 30 (12.0) 
 
 
Current smoker 23 (9.1) 25 (4.8) 4 (5.0) 14 (5.6) 
 
Physical activity level  
     
 




5.09 (2.72) 5.07 (2.78) 5.15 (2.93) 5.16 (2.77) 0.982 
Clinical/biochemical measures  
Mean BMI (kg/m
2
) 22.5 (2.2) 27.2 (3.7) 22.7 (1.9) 27.7 (3.5) < 0.001* 
BMI group, n (%) 
    
< 0.001* 
 
Overweight 86 (34.1) 94 (18.1) 23 (28.8) 38 (15.1) 
 
 
Obesity 27 (10.7) 370 (71.4) 9 (11.3) 195 (77.7) 
 
Waist circumference (cm) 
     
 
Female 83.3 (4.8) 91.0 (8.0) 75.5 (3.0) 91.4 (7.9) < 0.001* 
 
Male 83.3 (4.8) 97.0 (6.1) 85.1 (3.9) 98.8 (7.5) < 0.001* 
Systolic BP (mmHg) 140.7 (16.1) 142.1 (15.8) 140.7 (15.0) 142.6 (15.4) 0.483 
Diastolic BP (mmHg) 82.7 (9.2) 83.9 (9.7) 83.3 (9.5) 84.7 (9.3) 0.102 
Mean FPG at recruitment 
(mmol/l) 
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Total cholesterol (mmol/l) 4.9 (0.9) 4.9 (0.9) 5.3 (1.0) 5.3 (1.0) < 0.001* 
Triglycerides (mmol/l) 1.0 (0.3) 1.1 (0.3) 2.3 (0.6) 2.5 (0.9) < 0.001* 
HDL-cholesterol (mmol/l) 1.5 (0.4) 1.4 (0.3) 1.1 (0.3) 1.1 (0.3) < 0.001* 
LDL-cholesterol (mmol/l) 2.9 (0.8) 3.0 (0.8) 3.1 (0.9) 3.1 (0.9) 0.011* 
MVPA, moderate-to-vigorous physical activity. 
Normal waistline: < 80 cm in women; < 90 cm in men; central obesity: ≥ 80 cm in women, ≥ 90c m in men; 
normal triglyceride level: < 1.7 mmol/l; high triglyceride level: ≥ 1.7 mmol/l. 
Between-group differences were compared using one-way ANOVA test for continuous data and χ
2
 test for 
categorical variables. 
* 
†P-values were derived from either ANOVA test or χ
2
 test, where appropriate. 
 
 

















Any criteria, n (%) 71 (28.2) 179 (34.6) 24 (30.0) 131 (52.2) < 0.001* 
FPG criteria, n (%) 6 (2.4) 13 (2.5) 2 (2.5) 19 (7.6) 0.002* 
HbA1c criteria, n (%) 19 (7.5) 64 (12.4) 9 (11.3) 48 (19.1) 0.001* 
2h-OGTT criteria, n (%) 66 (26.2) 159 (30.7) 22 (27.5) 114 (45.4) < 0.001* 
FPG, fasting plasma glucose; OGTT, oral glucose tolerance test.  
Diabetes was defined according to the American Diabetes Association diagnostic criteria for diabetes [3] if the 
participant met any of the three definitions: FPG, ≥ 7.0 mmol/l; HbA1c, 47.5 mmol/mol (≥ 6.5%); and 2h-OGTT, 
≥ 11.1 mmol/l. 
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Central obesity with 
high triglyceride level 
Model 1 
    
HR (95% CI) Reference 1.185 (0.892, 1.573) 1.570 (0.984, 2.506) 1.630 (1.210, 2.196) 
P-value – 0.241 0.059 0.001* 
Model 2 
    
HR (95% CI) Reference 1.185 (0.891, 1.576) 1.585 (0.993, 2.530) 1.616 (1.198, 2.179) 
P-value – 0.242 0.054 0.002* 
Model 3 
    
HR (95% CI) Reference 1.176 (0.885, 1.563) 1.569 (0.982, 2.506) 1.581 (1.172, 2.134) 
P-value - 0.263 0.060 0.003* 
HR, hazard ratio; CI, confidence interval 
Diabetes was defined according to the American Diabetes Association diagnostic criteria for diabetes [3] if the 
participant met any of the three definitions: fasting plasma glucose, ≥ 7.0 mmol/l; HbA1c, ≥ 47.5 mmol/mol 
(≥ 6.5%); and 2 h-oral glucose tolerance test, ≥ 11.1 mmol/l. 
Multivariable Cox proportional hazards regressions were established. Model 1 adjusted for age, sex and baseline 
FPG. Model 2 further adjusted for family history, smoking status and systolic BP. Model 3 further adjusted for 
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